Aerobic training improves bone fragility by reducing the inflammatory microenvironment in bone tissue in type 2 diabetes

被引:1
|
作者
Cifuentes-Mendiola, Saul Ernesto [1 ,2 ]
Solis-Suarez, Diana Laura [1 ,3 ]
Martinez-Davalos, Arnulfo [4 ]
Perrusquia-Hernandez, Elias [5 ]
Garcia-Hernandez, Ana Lilia [1 ,6 ]
机构
[1] Natl Autonomous Univ Mexico UNAM, Sect Osteoimmunol & Oral Immunol, Lab Dent Res, FES Iztacala, Mexico City, Mexico
[2] Natl Autonomous Univ Mexico UNAM, Postgrad Biol Sci, Mexico City, Mexico
[3] Natl Autonomous Univ Mexico UNAM, Postgrad Dent Sciencies, Mexico City, Mexico
[4] Natl Autonomous Univ Mexico UNAM, Phys Inst, Mexico City, Mexico
[5] Natl Autonomous Univ Mexico UNAM, Neurobiol Oral Sensat & Movements Sect, Lab Dent Res, FES Iztacala, Mexico City, Mexico
[6] Natl Autonomous Univ Mexico UNAM, Sect Osteoimmunol & Oral Immunol, Lab Dent Res, FES Iztacala, A Jimenez Gallardo SN,San Sebastian Xhala Cuautitl, Mexico City, Mexico
关键词
Aerobic training; Type 2 Diabetes Mellitus; Bone disease; Bone biomechanics; Insulin resistance; INSULIN-RESISTANCE; EXERCISE; LIPOCALIN-2; MECHANISMS; OVERWEIGHT; MELLITUS; MICE;
D O I
10.1016/j.jbiomech.2022.111354
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Aerobic training (AT) is indicated in type 2 diabetes mellitus (T2DM) to control hyperglycaemia and inflam-mation. AT improves bone microarchitecture and resistance to fracture. The intensity of AT and the mechanisms that lead to the improvement in bone quality are still unknown. Using a mouse model of T2DM, we evaluated the effects of two intensities of forced AT. We divided mice into: sedentary (SED), T2DM-SED, low runners (LOW), T2DM-LOW, high runners (HIGH) and T2DM-HIGH. The AT for low was 8 m/minute (m/min); 5 degrees slope or high 18 m/min; 15 degrees slope for 2 months. We measured metabolic parameters, the serum cytokines concentration, lipocalin-2 (LCN-2) and adiponectin; and the tibial concentrations of LCN-2, tumour necrosis factor alpha (TNF-alpha) and protein carbonylation (CO). We evaluated femur morphometry and biomechanical properties. We per-formed multiple correlation analysis. The T2DM-LOW versus T2DM-SED group, shown an increase of interleukin (IL)-10 (417 +/- 90 vs 102 +/- 25 pg/mL) and improved trabecular bone (BV/TV: 31.8 +/- 2.3 vs 19.25 +/- 1.4%; Tb. Sp.: 1.62 +/- 0.02 vs 2.0 +/- 0.07 mm), by a decrease bone CO (3.4 +/- 0.1 vs 6.0 +/- 0.5 nmol/mg), bone TNF-alpha (84 +/- 4 vs 239 +/- 13 pg/mL) and LCN-2 (2887 +/- 23 vs 3418 +/- 105 pg/mL). The T2DM-HIGH versus T2DM-SED group showed a greater hypoglycaemic effect (228 +/- 10 vs 408 +/- 5 mg/dL), with improved cortical bone density (0.26 +/- 0.012 vs 0.21 +/- 0.007 mm) and fracture resistance (102 +/- 8 vs 78 +/- 5 MPa), by a reduction of bone TNF-alpha (77 +/- 34 vs 239 +/- 13 pg/mL); LCN-2 (2768 +/- 20 vs 3418 +/- 105 pg/mL) and CO (4.8 +/- 0.5 vs 6.0 +/- 0.5 nmol/mg). In conclusion, AT improves bone morphometry and biomechanical properties by reducing the bone inflammatory microenvironment.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Impaired bone healing in type 2 diabetes is caused by defective bone microenvironment functions of skeletal progenitor cells
    Figeac, Florence
    Tencerova, Michaela
    Ali, Dalia
    Andersen, Thomas L.
    Appadoo, Dan Remi
    Kerchkofs, Greet
    Kowal, Justyna Magdalena
    Ditzel, Nicholas
    Kassem, Moustapha
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 124 - 124
  • [22] Bone turnover and bone balance in type 2 diabetes
    Duseja, Ankita
    Gossiel, Fatma
    Paggiosi, Margaret
    Walsh, Jennifer
    Frost, Morten
    Hermann, Pernille
    Eastell, Richard
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 312 - 312
  • [23] Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus
    Hamann, Christine
    Rauner, Martina
    Hoehna, Yvonne
    Bernhardt, Ricardo
    Mettelsiefen, Jan
    Goettsch, Claudia
    Guenther, Klaus-Peter
    Stolina, Marina
    Han, Chun-Ya
    Asuncion, Franklin J.
    Ominsky, Michael S.
    Hofbauer, Lorenz C.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (03) : 627 - 638
  • [24] Role of advanced glycation endproducts in bone fragility in type 1 diabetes
    Rubin, Mishaela R.
    Dhaliwal, Ruban
    BONE, 2024, 178
  • [25] Bone fragility in type 1 diabetes: new insights and future steps
    Napoli, Nicola
    Conte, Caterina
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (07): : 475 - 476
  • [26] Fracture Risk Assessment Tool May Not Indicate Bone Fragility in Women With Type 2 Diabetes
    Ohira, Masahiro
    Suzuki, Sawako
    Yoshida, Tomohiko
    Koide, Hisashi
    Tanaka, Tomoaki
    Tatsuno, Ichiro
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2020, 360 (05): : 552 - 559
  • [27] METABOLISM OF BONE TISSUE IN TYPE 1 DIABETES MELLITUS
    Safarova, S. S.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S171 - S171
  • [28] Type 2 Diabetes and Bone Disease
    Lopez, Norma
    Cohen, Sara M.
    Emanuele, Maryann
    CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM, 2023, 21 (1-4): : 21 - 31
  • [29] Type 2 diabetes mellitus and bone
    Compston, J.
    JOURNAL OF INTERNAL MEDICINE, 2018, 283 (02) : 140 - 153
  • [30] Type 2 Diabetes and Bone Disease
    Norma Lopez
    Sara M. Cohen
    Maryann Emanuele
    Clinical Reviews in Bone and Mineral Metabolism, 2023, 21 : 21 - 31